What is the difference between ALBUTEROL and UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE?

ALBUTEROL and UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE are both Beta-2 Agonist Bronchodilators, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Is Albuterol the same as Anoro Ellipta?

No. Albuterol (ALBUTEROL) and Anoro Ellipta (UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, ALBUTEROL or UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from ALBUTEROL to UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

ALBUTEROL vs UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Compare ALBUTEROL (Albuterol) and UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE (Anoro Ellipta) — clinical data, side effects, and patient experiences.

ALBUTEROL

Albuterol, ProAir, Ventolin · Beta-2 Agonist Bronchodilator

How it works

Other agent

Approved for

INDICATIONS AND USAGE Albuterol tablets

USP are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.

OralTablet

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Anoro Ellipta · Beta-2 Agonist Bronchodilator

How it works

12.1 Mechanism of Action ANORO ELLIPTA ANORO ELLIPTA contains both umeclidinium and vilanterol. The mechanisms of action described below for the individual components apply to ANOR...

Approved for

an anticholinergic

and vilanterol

a long-acting beta 2 -adrenergic agonist (LABA)

5.2 )

Respiratory (inhalation)Tablet

Quick Comparison

ALBUTEROLUMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Drug Class

Beta-2 Agonist Bronchodilator

Route

Oral

Respiratory (inhalation)

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ALBUTEROL

Shortness of Breath

>10%

Drug Not Working

1-10%

Cough

1-10%

Fatigue

1-10%

Headache

1-10%

Nausea

1-10%

Diarrhea

0.1-1%

General Unwellness

0.1-1%

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Shortness of Breath

>10%

Drug Not Working

>10%

Cough

1-10%

Fatigue

0.1-1%

Headache

0.1-1%

Condition Worsened

0.1-1%

FDA Warnings

ALBUTEROL

WARNINGS Paradoxical Bronchospasm Albuterol tablets can produce paradoxical bronchospasm, which may be life threatening

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

5 WARNINGS AND PRECAUTIONS • LABA monotherapy (without an inhaled corticosteroid) for asthma increases the risk of serious asthma-related events
2 ) • Do not use in combination with additional therapy containing a LABA because of risk of overdose
1 Serious Asthma-Related Events – Hospitalizations, Intubations, Death The safety and effectiveness of ANORO ELLIPTA in patients with asthma have not been established
Use of LABA as monotherapy (without ICS) for asthma is associated with an increased risk of asthma-related death

Clinical Trial Data

No head-to-head clinical studies found for ALBUTEROL vs UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE.

ALBUTEROL vs UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE: What You Should Know

Key Differences

Both ALBUTEROL and UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE belong to the Beta-2 Agonist Bronchodilator class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. ALBUTEROL is administered via Oral, whereas UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE uses Respiratory (inhalation). Route of administration can affect onset of action and patient adherence.

Safety Considerations

ALBUTEROL carries 1 FDA warning. UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

ALBUTEROL vs FORMOTEROL FUMARATE→ALBUTEROL vs LEVALBUTEROL HYDROCHLORIDE→ALBUTEROL vs FORMOTEROL FUMARATE DIHYDRATE→ALBUTEROL vs TIOTROPIUM BROMIDE AND OLODATEROL→ALBUTEROL vs FLUTICASONE PROPIONATE AND SALMETEROL→ALBUTEROL vs ALBUTEROL SULFATE→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ALBUTEROL: DailyMed label · FAERS adverse events · ClinicalTrials.gov
UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

ALBUTEROL vs UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Compare ALBUTEROL (Albuterol) and UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE (Anoro Ellipta) — clinical data, side effects, and patient experiences.

ALBUTEROL

Albuterol, ProAir, Ventolin · Beta-2 Agonist Bronchodilator

How it works

Other agent

Approved for

INDICATIONS AND USAGE Albuterol tablets

USP are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.

OralTablet

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Anoro Ellipta · Beta-2 Agonist Bronchodilator

How it works

12.1 Mechanism of Action ANORO ELLIPTA ANORO ELLIPTA contains both umeclidinium and vilanterol. The mechanisms of action described below for the individual components apply to ANOR...

Approved for

an anticholinergic

and vilanterol

a long-acting beta 2 -adrenergic agonist (LABA)

5.2 )

Respiratory (inhalation)Tablet

Quick Comparison

ALBUTEROLUMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Drug Class

Beta-2 Agonist Bronchodilator

Route

Oral

Respiratory (inhalation)

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ALBUTEROL

Shortness of Breath

>10%

Drug Not Working

1-10%

Cough

1-10%

Fatigue

1-10%

Headache

1-10%

Nausea

1-10%

Diarrhea

0.1-1%

General Unwellness

0.1-1%

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Shortness of Breath

>10%

Drug Not Working

>10%

Cough

1-10%

Fatigue

0.1-1%

Headache

0.1-1%

Condition Worsened

0.1-1%

FDA Warnings

ALBUTEROL

WARNINGS Paradoxical Bronchospasm Albuterol tablets can produce paradoxical bronchospasm, which may be life threatening

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

5 WARNINGS AND PRECAUTIONS • LABA monotherapy (without an inhaled corticosteroid) for asthma increases the risk of serious asthma-related events
2 ) • Do not use in combination with additional therapy containing a LABA because of risk of overdose
1 Serious Asthma-Related Events – Hospitalizations, Intubations, Death The safety and effectiveness of ANORO ELLIPTA in patients with asthma have not been established
Use of LABA as monotherapy (without ICS) for asthma is associated with an increased risk of asthma-related death

Clinical Trial Data

No head-to-head clinical studies found for ALBUTEROL vs UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE.

ALBUTEROL vs UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ALBUTEROL: DailyMed label · FAERS adverse events · ClinicalTrials.gov
UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE: DailyMed label · FAERS adverse events · ClinicalTrials.gov